108 related articles for article (PubMed ID: 747042)
21. The effect of various antilymphocyte sera (ALS) on the migration of spleen fragment cells.
Svejcar J; Pekárek J; Johanovský J
Immunology; 1971 Jul; 21(1):45-9. PubMed ID: 5314712
[TBL] [Abstract][Full Text] [Related]
22. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
23. Leucocyte migration test with spleen extracts in patients on chronic hemodialysis.
Erard MD; Galanaud P; Dormont J
Biomedicine; 1973 Nov; 19(11):499-502. PubMed ID: 4599841
[No Abstract] [Full Text] [Related]
24. [Inhibition of leukocyte migration. Its application to the immunological study of human lymphomas].
Braun M; Bachmann AE
Medicina (B Aires); 1971; 31(1):6-12. PubMed ID: 4104818
[No Abstract] [Full Text] [Related]
25. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
27. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte migration in malignant disease.
Crowther D; Wagstaff J
Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
[TBL] [Abstract][Full Text] [Related]
29. Leucocyte migration inhibition test as an index of immunological response to measles virus I. Effect of the environment and measles virus on migration of monkey leucocytes.
Kańtoch M; Litwińska B; Falecka W; Sadowski W; Lityńska J
Acta Microbiol Pol; 1977; 26(4):421-7. PubMed ID: 75672
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological analysis of the immunoreactivity of normal lymphoid cells and lymphomas with the monoclonal antibody OPD4.
O'Grady J; Blaikie AJ; Howie SE; Salter DM; Krajewski AS
J Pathol; 1991 Jun; 164(2):119-25. PubMed ID: 2072211
[TBL] [Abstract][Full Text] [Related]
31. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
Wilson GB; Fudenberg HH; Bahm VJ
Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
[No Abstract] [Full Text] [Related]
32. A one-stage test for simultaneous study of migration inhibition factor of peripheral leukocytes (LIF) and migration inhibition factor of mouse spleen cells (MSIF).
Skopińska E; Nowaczyk
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):171-5. PubMed ID: 375867
[TBL] [Abstract][Full Text] [Related]
33. Lymphoma associated antigen (LAA)--a unique biomarker for lymphomas.
Udayachander M; Meenakshi A; Sakthivel R; Sreenivasan R; Krishnan RH; Padma S
Indian J Biochem Biophys; 1991; 28(5-6):461-6. PubMed ID: 1812083
[TBL] [Abstract][Full Text] [Related]
34. [Epstein-Barr virus and malignant lymphomas--studies on incidence and localization of viral DNA].
Herbst H; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Bergholz M; Kneba M; Krieger G; Stein H
Verh Dtsch Ges Pathol; 1990; 74():386-9. PubMed ID: 1708622
[TBL] [Abstract][Full Text] [Related]
35. [Sensitization of the leukocytes of stomach cancer patients to extracts of the tumor].
Kurtenkov OA; Miliukhina LM
Vopr Onkol; 1985; 31(5):31-6. PubMed ID: 4013127
[TBL] [Abstract][Full Text] [Related]
36. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay.
Borkowsky W; Lawrence HS
J Immunol; 1979 Oct; 123(4):1741-8. PubMed ID: 479597
[No Abstract] [Full Text] [Related]
37. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
Abai AM; Fekete B
Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
[TBL] [Abstract][Full Text] [Related]
38. Disorders of the lymphatic homing and MIF production by the lymphocytes of thymus, spleen and lymph nodes after liver injury caused by portocaval shunt in rats.
Andrzejewski W; Pokoca LT; Tchórzewski H
Arch Immunol Ther Exp (Warsz); 1987; 35(6):753-8. PubMed ID: 3334006
[TBL] [Abstract][Full Text] [Related]
39. [Staging in non-Hodgkin's lymphomas].
Wilke C; Peiper HJ; Gregl A; Nagel G; Pavić S; Pavić Z; Böhlken M; Zinn H
Z Lymphol; 1988 Jul; 12(1):5-14. PubMed ID: 3176607
[TBL] [Abstract][Full Text] [Related]
40. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
